Deferred versus Expedited Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis During the SARS-CoV-2 Pandemic (AS DEFER): A Research Letter
Main Authors: | Jonas Lanz, Christoph Ryffel, Noé Corpataux, Nicole Reusser, Taishi Okuno, Bettina Langhammer, David Reineke, Fabien Praz, Stefan Stortecky, Stephan Windecker, Thomas Pilgrim |
---|---|
Format: | Article |
Language: | English |
Published: |
Ubiquity Press
2021-04-01
|
Series: | Global Heart |
Subjects: | |
Online Access: | https://globalheartjournal.com/articles/989 |
Similar Items
-
Staging cardiac damage associated with aortic stenosis in patients undergoing transcatheter aortic valve implantation
by: Taishi Okuno, et al.
Published: (2021-04-01) -
Will Transcatheter Aortic Valve Replacement (TAVR) be the Primary Therapy for Aortic Stenosis?
by: Jose F. Condado, MD, MS, et al.
Published: (2016-05-01) -
Update on Transcatheter Aortic Valve Replacement
by: Morgan H. Randall, et al.
Published: (2020-02-01) -
Aortic Valve Replacement for Aortic Stenosis in Elderly Patients (75 Years or Older)
by: Bongyeon Sohn, et al.
Published: (2018-10-01) -
Percutaneous aortic valve implantation in bicuspid aortic valve: A case report
by: Seyed Ebrahim Kassaian, et al.
Published: (2015-05-01)